Overview

This trial is active, not recruiting.

Condition vaccination
Treatments educational text message reminders, conventional text message reminders
Sponsor Columbia University
Collaborator Pfizer
Start date August 2014
End date June 2015
Trial size 520 participants
Trial identifier NCT02231957, AAAM3756

Summary

There are a growing number of adolescents with chronic medical conditions in the United States. The Advisory Committee on Immunization Practices (ACIP) recommends HPV vaccination and annual influenza vaccination of all adolescents. Pneumococcal polysaccharide vaccination is also recommended for certain high-risk patients. Limited studies suggest that vaccination coverage of this population remains sub-optimal. Text message vaccine reminder/recall has been shown to be effective in increasing uptake of select pediatric and adolescents vaccines, but has yet to be examined among patients with chronic medical conditions who may also face unique barriers to vaccination. This intervention aims to implement and evaluate the use of text message vaccine reminders among urban low-income minority adolescents with chronic medical conditions. This investigator-initiated study is supported in part by a grant from the Pfizer Medical Education Group.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Allocation randomized
Intervention model parallel assignment
Masking double blind (caregiver, investigator, outcomes assessor)
Primary purpose health services research
Arm
(Experimental)
receipt of education-embedded text message vaccine reminders
educational text message reminders educational text message vaccine reminders
(Active Comparator)
receipt of conventional text message vaccine reminders
conventional text message reminders conventional text message vaccine reminders

Primary Outcomes

Measure
Percentage of eligible subjects who received HPV1, influenza, and/or pneumococcal vaccine(s)
time frame: 12 weeks after intervention start

Secondary Outcomes

Measure
Percentage of eligible subjects who received HPV1, influenza, and/or pneumococcal vaccine(s)
time frame: 4 weeks after intervention start
Percentage of eligible subjects who received HPV1, influenza, and/or pneumococcal vaccine(s)
time frame: 24 weeks after intervention start
Percentage of eligible subjects with missed opportunities for HPV1, influenza, and/or pneumococcal vaccination
time frame: 4 weeks after intervention start
Percentage of eligible subjects with missed opportunities for HPV1, influenza, and/or pneumococcal vaccination
time frame: 12 weeks after intervention start
Percentage of eligible subjects with missed opportunities for HPV1, influenza, and/or pneumococcal vaccination
time frame: 24 weeks after intervention start

Eligibility Criteria

Male or female participants at least 11 years old.

Inclusion Criteria: Parent with 1. adolescent aged 11-17 years; 2. adolescent with ≥1 chronic medical condition; 3. adolescent with clinic visit in last 12 months; 4. cell phone number listed in hospital registration system Exclusion Criteria: Parent who: 1. does not speak English or Spanish; 2. is unwilling to receive text message vaccine reminders; 3. anticipates moving from area in coming 12 months

Additional Information

Official title Text Message Vaccine Reminders for Adolescents With Chronic Medical Conditions
Principal investigator Annika M Hofstetter, MD, PhD, MPH
Trial information was received from ClinicalTrials.gov and was last updated in July 2016.
Information provided to ClinicalTrials.gov by Columbia University.